UROMITEXAN
Google image searchProduct monograph
Active ingredient
mesna, 100 MG/ML
DIN: 02241411
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS, ORAL
Schedule: Prescription
Company: BAXTER CORPORATION
Date: 16-JAN-2004
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AF — Detoxifying agents for antineoplastic treatment (ATC, ATC/DDD)
- V03AF01 — MESNA (ATC/DDD)
Reference brand drug: Uromitexan